Systems biology of tuberculosis: Insights for drug discovery

Understanding the Dynamics of Biological Systems: Lessons Learned from Integrative Systems Biology

Volumn , Issue , 2011, Pages 83-110

  Raman, Karthik ^a   Chandra, Nagasuma ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052698646     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7964-3_5     Document Type: Chapter

References (85)

1. R. Albert and H. G. Othmer. The topology of the regulatory interactions predicts the expression pattern of the segment polarity genes in Drosophila melanogaster. J Theor Biol, 223(1):1-18, 2003
2. P. W. Anderson. More is different. Science, 177(4047):393-396, 1972
3. S. Anishetty, M. Pulimi, and G. Pennathur. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem, 29(5):368-378, 2005
4. G. Apic, T. Ignjatovic, S. Boyer, and R. B. Russell. Illuminating drug discovery with biological pathways. FEBS Lett, 579(8):1872-1877, 2005
5. G. Balazsi, A. P. Heath, L. Shi, and M. L. Gennaro. The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest. Mol Syst Biol, 4:225, 2008
6. A-L. Barabasi and Z. N. Oltvai. Network biology: Understanding the cells functional organization. Nat Rev Genet, 5(2):101-113, 2004
7. C. E. Barry III, R. E. Lee, K. Mdluli, A. E. Simpson, B. G. Schroeder, R. A. Slayden, and Y. Yuan. Mycolic acids: Structure, biosynthesis and physiological functions. Prog Lipid Res, 37:143-179, 1998
8. S. A. Becker and B. . Palsson. Three factors underlying incorrect in silico predictions of essential metabolic genes. BMC Syst Biol, 2:14, 2008
9. E. Beretta, M. Carletti, D. E. Kirschner, and S. Marino. Stability analysis of a mathematical model of the immune response with delays, In: Mathematics for life science and medicine, pages 177-206. Springer, Berlin, 2007
10. D. J. V. Beste, T. Hooper, G. Stewart, B. Bonde, C. Avignone-Rossa, M. E. Bushell, P. Wheeler, S. Klamt, A. M. Kierzek, and J. McFadden. GSMN-TB: A web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol, 8:R89, 2007
11. H. P. J. Bonarius, G. Schmid, and J. Tramper. Flux analysis of underdetermined metabolic networks: The quest for the missing constraints. Trends Biotechnol, 15(8):308-314, 1997
12. S. Bonora and G. Di Perri. Interactions between antiretroviral agents and those used to treat tuberculosis: Clinical pharmacology of antiretroviral drugs. Curr Opin HIV & AIDS, 3:306-312, 2008
13. H. I. Boshoff, T. G. Myers, B. R. Copp, M. R. McNeil, M. Wilson, and C. E. Barry III. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: Novel insights into drug mechanisms of action. J Biol Chem, 279(38):40174-40184, 2004
14. A. Bruckner, C. Polge, N. Lentze, D. Auerbach, and U. Schlattner. Yeast two-hybrid, a powerful tool for systems biology. Int JMol Sci, 10(6):2763-2788, 2009
15. L. Cabusora, E. Sutton, A. Fulmer, and C. V. Forst. Differential network expression during drug and stress response. Bioinformatics, 21(12):2898-2905, 2005
16. J-C. Camus, M. J. Pryor, C. Medigue, and S. T. Cole. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology, 148(10):2967-2973, 2002
17. B. L. Claus and D. J. Underwood. Discovery informatics: Its evolving role in drug discovery. Drug Discov Today, 7:957-966, 2002
18. S. T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogerand, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 393:537-544, 1998
19. A. Cornish-Bowden and M. L. Cardenas. Metabolic analysis in drug design. C R Biol, 326(5): 509-515, 2003
20. D. C. Crick, S. Mahapatra, and P. J. Brennan. Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology, 11:107R-118R, 2001
21. P. Csermely, V. A goston, and S. Pongor. The efficiency of multi-target drugs: The network approach might help drug design. Trends Pharmacol Sci, 26:178-182, 2005
22. T. Dandekar, B. Snel, M. A. Huynen, and P. Bork. Conservation of gene order: A fingerprint of proteins that physically interact. Trends Biochem Sci, 23(9):324-328, 1998
23. E. J. Davidov, J. M. Holland, E. W. Marple, and S. Naylor. Advancing drug discovery through systems biology. Drug Discov Today, 8(4):175-183, 2003
24. J. Doyle. Computational biology. Beyond the spherical cow. Nature, 411(6834):151-152, 2001
25. P. Draper and M. Daffe. The cell envelope of Mycobacterium tuberculosis with special reference to the capsule and outer permeability barrier. In: Stewart T. Cole, Kathleen D. Eisenach, David N. McMurray, and William R. Jacobs Jr., editors, Tuberculosis and the tubercle bacillus, pages 261-273. American Society of Microbiology Press, 2005
26. E. Dubnau, J. Chan, C. Raynaud, V. P. Mohan, M. A. Laneelle, K. Yu, A. Quemard, I. Smith, and M. Daffe. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol, 36(3):630-637, 2000
27. J. S. Edwards and B. . Palsson. The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities. Proc Natl Acad Sci USA, 97(10):5528-5533, 2000
28. J. S. Edwards, M. W. Covert, and B. . Palsson. Metabolic modelling of microbes: The fluxbalance approach. Environ Microbiol, 4(3):133-133, 2002
29. S. Fields and O. Song. A novel genetic system to detect protein-protein interactions. Nature, 340 (6230):245-246, 1989
30. C. V. Forst. Host-pathogen systems biology. Drug Discov Today, 11(5-6):220-227, 2006
31. J. Forster, I. Famili, P. Fu, B. . Palsson, and J. Nielsen. Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res, 13(2):244-253, 2003
32. M. S. Glickman, J. S. Cox, and W. R. Jacobs Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell, 5(4): 717-727, 2000
33. S. Gupta, S. S. Bisht, R. Kukreti, S. Jain, and S. K. Brahmachari. Boolean network analysis of a neurotransmitter signaling pathway. J Theor Biol, 244(3):463-469, Feb 2007
34. S. Hasan, S. Daugelat, P. S. Rao, and M. Schreiber. Prioritizing genomic drug targets in pathogens: Application to Mycobacterium tuberculosis. PLoS Comput Biol, 2(6):e61, 2006
35. P. J. Hunter and T. K. Borg. Integration from proteins to organs: The Physiome project. Nat Rev Mol Cell Biol, 4(3):237-243, 2003
36. T. Ideker, O. Ozier, B. Schwikowski, and A. F. Siegel. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics, 18 Suppl 1:S233-S240, 2002
37. P-E. Jacques, A. L. Gervais, M. Cantin, J-F. Lucier, G. Dallaire, G. Drouin, L. Gaudreau, J. Goulet, and J. Brzezinski. MtbRegList, a database dedicated to the analysis of transcriptional regulation in Mycobacterium tuberculosis. Bioinformatics, 21(10):2563-2565, 2005
38. N. Jamshidi and B. . Palsson. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol, 1:26, 2007
39. H. Jeong, S. P.Mason, A-L. Barabasi, and Z. N. Oltvai. Lethality and centrality in protein networks. Nature, 411(6833):41-42, 2001
40. Y. Kalidas and N. Chandra. Pocketdepth: A new depth based algorithm for identification of ligand binding sites in proteins. J Struct Biol, 161(1):31-42, 2008
41. K. J. Kauffman, P. Prakash, and J. S. Edwards. Advances in flux balance analysis. Curr Opin Biotechnol, 14(5):491-496, 2003
42. S. A. Kauffman. Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol, 22(3):437-467, 1969
43. D. Kirschner and S. Marino. Mycobacterium tuberculosis as viewed through a computer. Trends Microbiol, 13(5):206-211, 2005
44. E. M. Marcotte, M. Pellegrini, H-L. Ng, D. W. Rice, T. O. Yeates, and D. Eisenberg. Detecting protein function and protein-protein interactions from genome sequences. Science, 285(5428): 751-753, 1999
45. S. Marino and D. E. Kirschner. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol, 227(4):463-486, 2004
46. S. Marino, S. Pawar, C. L. Fuller, T. A. Reinhart, J. L. Flynn, and D. E. Kirschner. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol, 173(1):494-506, 2004
47. S. Marino, E. Beretta, and D. E. Kirschner. The role of delays in innate and adaptive immunity to intracellular bacterial infection. Math Biosci Eng, 4(2):261-288, 2007a
48. S. Marino, D. Sud, H. Plessner, L. P. Lin, J. Chan, J. L. Flynn, and D. E. Kirschner. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput Biol, 3(10):1909-1924, 2007b
49. K.Mdluli and M. Spigelman. Novel targets for tuberculosis drug discovery. Curr Opin Pharmacol, 6(5):459-467, 2006
50. P. Nunn, B. Williams, K. Floyd, C. Dye, G. Elzinga, and M. Raviglione. Tuberculosis control in the era of HIV. Nat Rev Immunol, 5(10):819-826, 2005
51. J. A. Papin, T. Hunter, B. . Palsson, and S. Subramaniam. Reconstruction of cellular signaling networks and analysis of their properties. Nat RevMol Cell Biol, 6(2):99-111, 2005
52. M. Pellegrini, E. M. Marcotte, M. J. Thompson, D. Eisenberg, and T. O. Yeates. Assigning protein functions by comparative genome analysis: Protein phylogenetic profiles. Proc Natl Acad Sci USA, 96(8):4285-4288, 1999
53. G. Ramachandraiah and N. Chandra. Sequence and structural determinants of mannose recognition. Proteins, 39(4):358-364, 2000
54. K. Raman. Systems-level modelling and simulation of Mycobacterium tuberculosis: Insights for drug discovery. PhD thesis, Indian Institute of Science, Bangalore, 2008
55. K. Raman and N. Chandra. Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance. BMC Microbiol, 8:234, 2008
56. K. Raman and N. Chandra. Flux balance analysis of biological systems: Applications and challenges. Brief Bioinform, 10(4):435-449, 2009
57. K. Raman, P. Rajagopalan, and N. Chandra. Flux balance analysis of mycolic acid pathway: Targets for anti-tubercular drugs. PLoS Comput Biol, 1(5):e46, 2005
58. K. Raman, Y. Kalidas, and N. Chandra. targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol, 2(1):109, 2008
59. K. Raman, R. Vashisht, and N. Chandra. Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Mol Biosyst, 5:1740-1751, 2009
60. K. Raman, A. G. Bhat, and N. Chandra. A systems perspective of hostpathogen interactions: Predicting disease outcome in tuberculosis. Mol Biosyst, 6:516-530, 2010
61. K. Raman, Y. Kalidas, and N. Chandra. Model-driven drug discovery: Principles and practices, Biological database modeling, pages 163-188. Artech House, New York, 2007
62. J. C. J. Ray and D. E. Kirschner. Requirement for multiple activation signals by anti-inflammatory feedback in macrophages. J Theor Biol, 241(2):276-294, 2006
63. J. C. J. Ray, J.Wang, J. Chan, and D. E. Kirschner. The timing of TNF and IFN- signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J Theor Biol, 252(1):24-38, 2008
64. J. L. Reed, I. Famili, I Thiele, and B. . Palsson. Towards multidimensional genome annotation. Nat Rev Genet, 7(2):130-141, 2006a
65. J. L. Reed, T. R. Patel, K. H. Chen, A. R. Joyce, M. K. Applebee, D. D. Herring, O. T. Bui, E. M. Knight, S. S. Fong, and B. . Palsson. Systems approach to refining genome annotation. Proc Natl Acad Sci USA, 103(46):17480-17484, Nov 2006b
66. C. M. Sassetti, D. M. Boyd, and E. J. Rubin. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol, 48(1):77-84, 2003
67. D. Schnappinger, S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J ExpMed, 198(5):693-704, 2003
68. J. L. Segovia-Juarez, S. Ganguli, and D. E. Kirschner. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol, 231 (3):357-376, 2004
69. I. Smith. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev, 16(3):463-496, 2003
70. M. Strong, T. G. Graeber, M. Beeby, M. Pellegrini, M. J. Thompson, T. O. Yeates, and D. Eisenberg. Visualization and interpretation of protein networks in Mycobacterium tuberculosis based on hierarchical clustering of genome-wide functional linkage maps. Nucleic Acids Res, 31(24):7099-7109, 2003
71. D. Sud, C. Bigbee, J. L. Flynn, and D. E. Kirschner. Contribution of CD8C T cells to control of Mycobacterium tuberculosis infection. J Immunol, 176(7):4296-4314, 2006
72. K. Takayama, C. Wang, and G. S. Besra. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev, 18:81-101, 2005
73. J. Thakar, M. Pilione, G. Kirimanjeswara, E. T. Harvill, and R. Albert. Modeling systems-level regulation of host immune responses. PLoS Comput Biol, 3(6):e109, 2007
74. T. Thomas. Boolean formalization of genetic control circuits. J Theor Biol, 42(3):563-585, 1973
75. K. D. Verkhedkar, K. Raman, N. Chandra, and S. Vishveshwara. Metabolome based reaction graphs of M. tuberculosis and M. leprae: A comparative network analysis. PLoS One, 2(9): e881, 2007
76. P. K. Vinod, B. Konkimalla, and N. Chandra. In-silico pharmacodynamics: Correlation of adverse effects of H2-antihistamines with histamine N-methyl transferase binding potential. Appl Bioinform, 5(3):141-150, 2006
77. C. Von Mering, L. J. Jensen, M. Kuhn, S. Chaffron, T. Doerks, B. Kruger, B. Snel, and P. Bork. STRING 7 - recent developments in the integration and prediction of protein interactions. Nucleic Acids Res, 35(Database issue):358-362, 2007
78. J. S. Waddell and P. D. Butcher. Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis. Curr Mol Med, 7(3):287-296, 2007
79. S. J. Waddell, R. A. Stabler, K. Laing, L. Kremer, R. C. Reynolds, and G. S. Besra. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb), 84(3-4):263-274, 2004
80. S. J. Waddell, P. D. Butcher, and N. G. Stoker. Rna profiling in host-pathogen interactions. Curr Opin Microbiol, 10(3):297-302, 2007
81. S. J. Waddell, K. Laing, C. Senner, and P. D. Butcher. Microarray analysis of defined Mycobacterium tuberculosis populations using rna amplification strategies. BMC Genomics, 9:94, 2008
82. J. E. Wigginton and D. E. Kirschner. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol, 166(3): 1951-1967, 2001
83. World Health Organisation. Global tuberculosis control: Surveillance, planning, financing: WHO report 2008. World Health Organisation, 2008 ISBN 978-9241563543
84. K. Yeturu and N. Chandra. PocketMatch: A new algorithm to compare binding sites in protein structures. BMC Bioinform, 9:543, 2008
85. D. Young, J. Stark, and D. E. Kirschner. Systems biology of persistent infection: Tuberculosis as a case study. Nat Rev Microbiol, 6(7):520-528, 2008